News from sanofi pasteur A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NYSE:SNY)

Sep 08, 2014, 14:14 ET

FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration...

Aug 13, 2014, 17:00 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published...

Jul 22, 2014, 08:45 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone® (Influenza...

May 19, 2014, 12:37 ET

Sanofi Pasteur annonce des résultats encourageants pour l'essai de Phase II du candidat vaccin Clostridium difficile au congrès de l'ECCMID

- L'étude montre que le vaccin induit une réponse immunitaire contre les principales toxines et permet d'identifier le dosage pour les...

May 19, 2014, 08:00 ET

Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational...

May 12, 2014, 08:19 ET

National Survey Reveals Mothers Are Unaware of the CDC Recommendations for Prevention of Meningococcal Meningitis, a Disease That Can Potentially Kill in 24 Hours

Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,1 a national survey revealed that more...

Apr 07, 2014, 12:09 ET

Gardasil® als 2-Dosen-Schema für Kinder im Alter von 9 bis 13 Jahren in der Europäischen Union zugelassen

 Ein neues 2-Dosen-Schema des HPV-Vierfachimpfstoffs Gardasil® ist ab sofort für Jugendliche...

Apr 07, 2014, 08:46 ET

Gardasil® recibe la aprobación en la UE para un programa de 2 dosis en niños de 9 a 13 años

 Un nuevo régimen de 2 dosis para Gardasil®, la vacuna cuadrivalente HPV, ya disponible para adolescentes Sanofi...

Apr 07, 2014, 03:00 ET

Le vaccin Gardasil® a été approuvé par l'Union européenne dans le cadre d'un schéma de vaccination en 2 doses chez les enfants entre 9 et 13 ans

 Le vaccin anti-HPV quadrivalent est désormais disponible dans le cadre d'un nouveau schéma de vaccination en 2 doses pour les...

Apr 01, 2014, 09:13 ET

Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has...

Mar 03, 2014, 01:00 ET

Les enfants du monde entier vont pouvoir bénéficier du vaccin polio inactivé, dans le cadre de l'éradication de la poliomyélite

- Sanofi Pasteur travaille avec ses partenaires internationaux pour fournir des quantités inégalées de vaccin polio inactivé...

Mar 03, 2014, 01:00 ET

Amplia disponibilidad de las vacunas antipoliomelíticas inactivadas para todos los niños del mundo en la iniciativa para la erradicación de la poliomielitis

Sanofi Pasteur, la división de vacunas de Sanofi (EURONEXT: SAN y NYSE: SNY), ha confirmado hoy su continuo compromiso con la comunidad...

Mar 03, 2014, 01:00 ET

Amplia disponibilidad de las vacunas antipoliomelíticas inactivadas para todos los niños del mundo en la iniciativa para la erradicación de la poliomielitis

- Sanofi Pasteur colabora con socios de todo el mundo para facilitar cantidades sin precedentes de vacunas antipoliomelíticas...

Mar 03, 2014, 01:00 ET

Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication

- Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi...

Feb 26, 2014, 08:05 ET

New National Survey: Majority of Moms Hold Incorrect Beliefs About Head Lice Management and Treatment

Although head lice are a common problem in families with school-aged children,1,2,3 a new national survey reveals that despite 60% of moms –...

Feb 03, 2014, 03:00 ET

Sanofi Pasteur lance une étude de phase III du vaccin candidat contre le Clostridium difficile en France

- L'essai clinique Cdiffense™ évaluera le vaccin contre une des principales causes d'infections nosocomiales potentiellement mortelles...

Sep 24, 2013, 09:30 ET

March of Dimes and Sanofi Pasteur Launch Sounds of Pertussis® "Grandparents' Corner" to Help Grandparents Better Protect Their Families from Whooping Cough

 March of Dimes and Sanofi Pasteur today launched Grandparents' Corner, a new online resource from the Sounds of Pertussis® Campaign, to...

Sep 19, 2013, 08:00 ET

Sanofi Pasteur is on the Hunt for The FLUgitives™ This Flu Season

 To help encourage more Americans to get their annual flu shot, Sanofi Pasteur announced today the launch of a national campaign to round up...

Aug 26, 2013, 08:00 ET

Sanofi Pasteur's Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced topline results of a large-scale, multi-center...

Aug 05, 2013, 14:50 ET

Sanofi Pasteur Initiates Phase III Study of Investigational Clostridium difficile Vaccine in the United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program...